instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Conjunctivitis'. | Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases.
BACKGROUND
There are few reports of COVID-19 in pediatric patients with rheumatic diseases. This study describes the clinical presentation and outcomes of COVID-19 in this population.
METHODS
We analyzed a single-center case series of ped... | HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34154620 | 19,607,288 | 2021-06-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal failure'. | Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases.
BACKGROUND
There are few reports of COVID-19 in pediatric patients with rheumatic diseases. This study describes the clinical presentation and outcomes of COVID-19 in this population.
METHODS
We analyzed a single-center case series of ped... | HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, PREDNISONE, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY | 34154620 | 19,607,289 | 2021-06-21 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases.
BACKGROUND
There are few reports of COVID-19 in pediatric patients with rheumatic diseases. This study describes the clinical presentation and outcomes of COVID-19 in this population.
METHODS
We analyzed a single-center case series of ped... | UNKNOWN | DrugDosageText | CC BY | 34154620 | 19,607,288 | 2021-06-21 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases.
BACKGROUND
There are few reports of COVID-19 in pediatric patients with rheumatic diseases. This study describes the clinical presentation and outcomes of COVID-19 in this population.
METHODS
We analyzed a single-center case series of ped... | UNKNOWN | DrugDosageText | CC BY | 34154620 | 19,607,288 | 2021-06-21 |
What was the dosage of drug 'RITUXIMAB'? | Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases.
BACKGROUND
There are few reports of COVID-19 in pediatric patients with rheumatic diseases. This study describes the clinical presentation and outcomes of COVID-19 in this population.
METHODS
We analyzed a single-center case series of ped... | UNKNOWN | DrugDosageText | CC BY | 34154620 | 19,607,288 | 2021-06-21 |
What was the dosage of drug 'TACROLIMUS'? | Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases.
BACKGROUND
There are few reports of COVID-19 in pediatric patients with rheumatic diseases. This study describes the clinical presentation and outcomes of COVID-19 in this population.
METHODS
We analyzed a single-center case series of ped... | UNKNOWN | DrugDosageText | CC BY | 34154620 | 19,607,289 | 2021-06-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transient ischaemic attack'. | Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase.
Agent of choice for thrombolytic therapy (TT) in prosthetic valve thrombosis (PVT) is unknown. 84 mitral obstructive-PVT episodes treated with TT (43: Tenecteplase; 41: Streptokinase) were inclu... | TENECTEPLASE | DrugsGivenReaction | CC BY-NC-ND | 34154758 | 19,021,504 | 2021 |
What was the administration route of drug 'TENECTEPLASE'? | Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase.
Agent of choice for thrombolytic therapy (TT) in prosthetic valve thrombosis (PVT) is unknown. 84 mitral obstructive-PVT episodes treated with TT (43: Tenecteplase; 41: Streptokinase) were inclu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34154758 | 19,021,504 | 2021 |
What was the dosage of drug 'TENECTEPLASE'? | Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase.
Agent of choice for thrombolytic therapy (TT) in prosthetic valve thrombosis (PVT) is unknown. 84 mitral obstructive-PVT episodes treated with TT (43: Tenecteplase; 41: Streptokinase) were inclu... | [0.50 MG/KG]/24 PER HOUR | DrugDosageText | CC BY-NC-ND | 34154758 | 19,021,504 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood follicle stimulating hormone decreased'. | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | TRIPTORELIN | DrugsGivenReaction | CC BY | 34156518 | 19,578,099 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood follicle stimulating hormone increased'. | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | TRIPTORELIN | DrugsGivenReaction | CC BY | 34156518 | 19,578,097 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood luteinising hormone decreased'. | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | TRIPTORELIN | DrugsGivenReaction | CC BY | 34156518 | 19,578,097 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood thyroid stimulating hormone decreased'. | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | TRIPTORELIN | DrugsGivenReaction | CC BY | 34156518 | 19,578,099 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | TRIPTORELIN | DrugsGivenReaction | CC BY | 34156518 | 19,578,097 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | TRIPTORELIN | DrugsGivenReaction | CC BY | 34156518 | 19,578,099 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ophthalmoplegia'. | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | TRIPTORELIN | DrugsGivenReaction | CC BY | 34156518 | 19,578,097 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pituitary apoplexy'. | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | TRIPTORELIN | DrugsGivenReaction | CC BY | 34156518 | 19,578,097 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Visual field defect'. | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | TRIPTORELIN | DrugsGivenReaction | CC BY | 34156518 | 19,569,711 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | TRIPTORELIN | DrugsGivenReaction | CC BY | 34156518 | 19,578,099 | 2021-08 |
What was the outcome of reaction 'Ophthalmoplegia'? | Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
OBJECTIVE
We aimed to review of literature on the clinical presentation, management and outcomes of pituitary apoplexy following gonadotrophic release hormone (GnRH) agonist ... | Recovered | ReactionOutcome | CC BY | 34156518 | 19,578,097 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myeloid leukaemia'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse event'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anti-platelet antibody'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacteraemia'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacterial infection'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Candida infection'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enteritis'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fungal infection'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes simplex'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory tract infection viral'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinusitis'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin bacterial infection'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Unevaluable event'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | CYTARABINE, FILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
What was the outcome of reaction 'Acute myeloid leukaemia'? | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | Fatal | ReactionOutcome | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
What was the outcome of reaction 'Infection'? | Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyeloc... | Fatal | ReactionOutcome | CC BY-NC-ND | 34156898 | 20,991,218 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Incidence of immune checkpoint inhibitor-mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score-matched retrospective study.
The risk of use of immune-mediated diarrhea and colitis (imDC) in patients with preexisting inflammatory bowel disease (IBD) i... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC | 34158318 | 20,012,107 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated enterocolitis'. | Incidence of immune checkpoint inhibitor-mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score-matched retrospective study.
The risk of use of immune-mediated diarrhea and colitis (imDC) in patients with preexisting inflammatory bowel disease (IBD) i... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC | 34158318 | 20,012,107 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Ileal inflammatory pseudotumor in adolescent male patient with prior Burkitt lymphoma: A challenging diagnosis.
Inflammatory pseudotumor is a rare benign mesenchymal pediatric neoplasm, that can mimic tumoral residue or relapse at metabolic imaging with nonspecific clinical presentation and difficult diagnosis. We pres... | DEXAMETHASONE, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34158889 | 19,830,098 | 2021-08 |
What was the outcome of reaction 'Inflammatory pseudotumour'? | Ileal inflammatory pseudotumor in adolescent male patient with prior Burkitt lymphoma: A challenging diagnosis.
Inflammatory pseudotumor is a rare benign mesenchymal pediatric neoplasm, that can mimic tumoral residue or relapse at metabolic imaging with nonspecific clinical presentation and difficult diagnosis. We pres... | Recovering | ReactionOutcome | CC BY-NC-ND | 34158889 | 19,830,098 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | AZATHIOPRINE, CYCLOSPORINE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34158959 | 19,985,005 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | AZATHIOPRINE, CYCLOSPORINE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34158959 | 19,985,005 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ketosis'. | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | CYCLOSPORINE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34158959 | 19,967,594 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | CYCLOSPORINE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34158959 | 19,963,089 | 2021-06 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34158959 | 19,870,385 | 2021-06 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34158959 | 19,967,594 | 2021-06 |
What was the administration route of drug 'PREDNISOLONE'? | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | Oral | DrugAdministrationRoute | CC BY-NC | 34158959 | 19,967,594 | 2021-06 |
What was the dosage of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | 15 MG/KG, DAILY | DrugDosageText | CC BY-NC | 34158959 | 19,870,385 | 2021-06 |
What was the dosage of drug 'MYCOPHENOLIC ACID'? | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | UP TITRATING DOSE | DrugDosageText | CC BY-NC | 34158959 | 19,869,590 | 2021-06 |
What was the outcome of reaction 'Hyperglycaemia'? | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | Recovered | ReactionOutcome | CC BY-NC | 34158959 | 19,963,089 | 2021-06 |
What was the outcome of reaction 'Ketosis-prone diabetes mellitus'? | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | Recovered | ReactionOutcome | CC BY-NC | 34158959 | 19,963,089 | 2021-06 |
What was the outcome of reaction 'Toxicity to various agents'? | A case of macrophage activation syndrome in a patient with anti-synthetase syndrome.
Anti-synthetase syndrome (ASS) is an autoimmune disease characterized by autoantibodies against an aminoacyl transfer RNA synthetase with clinical features including interstitial lung disease, non-erosive arthritis, myositis, Raynaud's... | Recovered | ReactionOutcome | CC BY-NC | 34158959 | 19,963,089 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arrhythmogenic right ventricular dysplasia'. | Sporadic and rapidly progressive arrhythmogenic right ventricular cardiomyopathy in a 12-year-old boy who was diagnosed with epilepsy.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is one of the leading causes of sudden cardiac death amongst young people and athletes. In this genetic disease, arrhythmia and fi... | DIVALPROEX SODIUM | DrugsGivenReaction | CC BY | 34158960 | 19,644,626 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiomyopathy'. | Sporadic and rapidly progressive arrhythmogenic right ventricular cardiomyopathy in a 12-year-old boy who was diagnosed with epilepsy.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is one of the leading causes of sudden cardiac death amongst young people and athletes. In this genetic disease, arrhythmia and fi... | AMIODARONE, BISOPROLOL, VALPROIC ACID | DrugsGivenReaction | CC BY | 34158960 | 19,517,089 | 2021-06 |
What was the dosage of drug 'AMIODARONE'? | Sporadic and rapidly progressive arrhythmogenic right ventricular cardiomyopathy in a 12-year-old boy who was diagnosed with epilepsy.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is one of the leading causes of sudden cardiac death amongst young people and athletes. In this genetic disease, arrhythmia and fi... | LOADING DOSE OF 5 MG/KG OVER 20 TO 60 MINUTES REPEATED TWICE UP TO A MAXIMUM DOSE OF 15 MG/KG | DrugDosageText | CC BY | 34158960 | 19,517,089 | 2021-06 |
What was the dosage of drug 'DIVALPROEX SODIUM'? | Sporadic and rapidly progressive arrhythmogenic right ventricular cardiomyopathy in a 12-year-old boy who was diagnosed with epilepsy.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is one of the leading causes of sudden cardiac death amongst young people and athletes. In this genetic disease, arrhythmia and fi... | 500 mg (milligrams). | DrugDosage | CC BY | 34158960 | 19,644,626 | 2021-06 |
What was the outcome of reaction 'Arrhythmogenic right ventricular dysplasia'? | Sporadic and rapidly progressive arrhythmogenic right ventricular cardiomyopathy in a 12-year-old boy who was diagnosed with epilepsy.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is one of the leading causes of sudden cardiac death amongst young people and athletes. In this genetic disease, arrhythmia and fi... | Fatal | ReactionOutcome | CC BY | 34158960 | 19,644,626 | 2021-06 |
What was the outcome of reaction 'Cardiomyopathy'? | Sporadic and rapidly progressive arrhythmogenic right ventricular cardiomyopathy in a 12-year-old boy who was diagnosed with epilepsy.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is one of the leading causes of sudden cardiac death amongst young people and athletes. In this genetic disease, arrhythmia and fi... | Fatal | ReactionOutcome | CC BY | 34158960 | 19,517,089 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease.
Background. Several cardiovascular manifestations of coronavirus disease 2019 (COVID-19) have been previously described. QT prolongation has been reported in COVID-19 infection in association with medications such as azithromycin... | ACETAMINOPHEN, CETIRIZINE HYDROCHLORIDE, CYCLIZINE, ENOXAPARIN, LACTULOSE, ROSUVASTATIN | DrugsGivenReaction | CC BY | 34158979 | 20,862,454 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease.
Background. Several cardiovascular manifestations of coronavirus disease 2019 (COVID-19) have been previously described. QT prolongation has been reported in COVID-19 infection in association with medications such as azithromycin... | ACETAMINOPHEN, CETIRIZINE HYDROCHLORIDE, CYCLIZINE, ENOXAPARIN, LACTULOSE, ROSUVASTATIN | DrugsGivenReaction | CC BY | 34158979 | 20,862,454 | 2021 |
What was the outcome of reaction 'Electrocardiogram QT prolonged'? | Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease.
Background. Several cardiovascular manifestations of coronavirus disease 2019 (COVID-19) have been previously described. QT prolongation has been reported in COVID-19 infection in association with medications such as azithromycin... | Recovered | ReactionOutcome | CC BY | 34158979 | 20,862,454 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diplopia'. | A Rare Case of Statin-Induced Diplopia: An Often-Overlooked but Reported Side Effect.
Statins are a class of medications indicated for atherosclerotic cardiovascular diseases and dyslipidemia. Ever since their introduction, various side effects have been reported with their use. Statin-induced myopathy is a well-establ... | ATORVASTATIN CALCIUM | DrugsGivenReaction | CC BY | 34159019 | 19,502,090 | 2021-05-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myopathy'. | A Rare Case of Statin-Induced Diplopia: An Often-Overlooked but Reported Side Effect.
Statins are a class of medications indicated for atherosclerotic cardiovascular diseases and dyslipidemia. Ever since their introduction, various side effects have been reported with their use. Statin-induced myopathy is a well-establ... | ATORVASTATIN CALCIUM | DrugsGivenReaction | CC BY | 34159019 | 19,502,090 | 2021-05-19 |
What was the outcome of reaction 'Diplopia'? | A Rare Case of Statin-Induced Diplopia: An Often-Overlooked but Reported Side Effect.
Statins are a class of medications indicated for atherosclerotic cardiovascular diseases and dyslipidemia. Ever since their introduction, various side effects have been reported with their use. Statin-induced myopathy is a well-establ... | Recovering | ReactionOutcome | CC BY | 34159019 | 19,502,090 | 2021-05-19 |
What was the outcome of reaction 'Myopathy'? | A Rare Case of Statin-Induced Diplopia: An Often-Overlooked but Reported Side Effect.
Statins are a class of medications indicated for atherosclerotic cardiovascular diseases and dyslipidemia. Ever since their introduction, various side effects have been reported with their use. Statin-induced myopathy is a well-establ... | Recovering | ReactionOutcome | CC BY | 34159019 | 19,502,090 | 2021-05-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenic sepsis'. | A Rare Presentation of Acute Respiratory Distress Due to Diffuse Large B-Cell Lymphoma of the Tongue Base.
Primary diffuse large B-cell lymphoma of the tongue base (BOT) is an extremely rare entity with only a few cases described in the English literature to date. The incidence of BOT non-Hodgkin's lymphoma (NHL) incre... | CYCLOPHOSPHAMIDE, DOXORUBICIN, METHOTREXATE, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34159026 | 19,497,787 | 2021-05-19 |
What was the administration route of drug 'METHOTREXATE'? | A Rare Presentation of Acute Respiratory Distress Due to Diffuse Large B-Cell Lymphoma of the Tongue Base.
Primary diffuse large B-cell lymphoma of the tongue base (BOT) is an extremely rare entity with only a few cases described in the English literature to date. The incidence of BOT non-Hodgkin's lymphoma (NHL) incre... | Intrathecal | DrugAdministrationRoute | CC BY | 34159026 | 19,497,787 | 2021-05-19 |
What was the dosage of drug 'METHOTREXATE'? | A Rare Presentation of Acute Respiratory Distress Due to Diffuse Large B-Cell Lymphoma of the Tongue Base.
Primary diffuse large B-cell lymphoma of the tongue base (BOT) is an extremely rare entity with only a few cases described in the English literature to date. The incidence of BOT non-Hodgkin's lymphoma (NHL) incre... | ONE COURSE OF INTRATHECAL METHOTREXATE | DrugDosageText | CC BY | 34159026 | 19,536,398 | 2021-05-19 |
What was the outcome of reaction 'Neutropenic sepsis'? | A Rare Presentation of Acute Respiratory Distress Due to Diffuse Large B-Cell Lymphoma of the Tongue Base.
Primary diffuse large B-cell lymphoma of the tongue base (BOT) is an extremely rare entity with only a few cases described in the English literature to date. The incidence of BOT non-Hodgkin's lymphoma (NHL) incre... | Recovered | ReactionOutcome | CC BY | 34159026 | 19,497,787 | 2021-05-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aphasia'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34159053 | 19,808,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Brain empyema'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34159053 | 19,808,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | CEFEPIME HYDROCHLORIDE, DAPTOMYCIN, METRONIDAZOLE | DrugsGivenReaction | CC BY | 34159053 | 19,831,714 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | CEFEPIME HYDROCHLORIDE, DAPTOMYCIN, METRONIDAZOLE | DrugsGivenReaction | CC BY | 34159053 | 19,831,714 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level below therapeutic'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34159053 | 19,808,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalitis'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34159053 | 19,808,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Meningitis'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34159053 | 19,808,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscular weakness'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34159053 | 19,808,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mycoplasma infection'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34159053 | 19,808,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34159053 | 19,808,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | DAPTOMYCIN | DrugsGivenReaction | CC BY | 34159053 | 19,798,576 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34159053 | 19,808,595 | 2021 |
What was the administration route of drug 'DAPTOMYCIN'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34159053 | 19,798,576 | 2021 |
What was the administration route of drug 'VANCOMYCIN HYDROCHLORIDE'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34159053 | 19,808,595 | 2021 |
What was the dosage of drug 'DAPTOMYCIN'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | 10 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 34159053 | 19,798,576 | 2021 |
What was the outcome of reaction 'Aphasia'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | Recovered | ReactionOutcome | CC BY | 34159053 | 19,808,595 | 2021 |
What was the outcome of reaction 'Brain empyema'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | Recovered | ReactionOutcome | CC BY | 34159053 | 19,808,595 | 2021 |
What was the outcome of reaction 'Encephalitis'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | Recovered | ReactionOutcome | CC BY | 34159053 | 19,808,595 | 2021 |
What was the outcome of reaction 'Meningitis'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | Recovered | ReactionOutcome | CC BY | 34159053 | 19,808,595 | 2021 |
What was the outcome of reaction 'Muscular weakness'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | Recovered | ReactionOutcome | CC BY | 34159053 | 19,808,595 | 2021 |
What was the outcome of reaction 'Mycoplasma infection'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | Recovered | ReactionOutcome | CC BY | 34159053 | 19,808,595 | 2021 |
What was the outcome of reaction 'Oedema'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | Recovered | ReactionOutcome | CC BY | 34159053 | 19,808,595 | 2021 |
What was the outcome of reaction 'Seizure'? | Intracranial Mycoplasma hominis infection following emergent craniectomy.
We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium.
Case
A 25-yea... | Recovered | ReactionOutcome | CC BY | 34159053 | 19,808,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure before pregnancy'. | Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report.
Ovarian hyperstimulation syndrome (OHSS) is a feared complication of controlled ovarian stimulation (COS) and can be associated with significant morbidity and mortality. Risk factors for OH... | CHORIOGONADOTROPIN ALFA, GANIRELIX ACETATE, WATER | DrugsGivenReaction | CC BY-NC-ND | 34159057 | 19,719,749 | 2021-07 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.